. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Transplant Rev (Orlando). 2019 Apr 5;33(3):115–129. doi: 10.1016/j.trre.2019.03.002

Table 1:

Models of Antibody-Mediated Rejection

First author (ref)	Species	Organ	Treatment regimen
Haanstra¹⁴²	Rhesus	Kidney	Anti-CD40 + Anti-CD86
Kawai¹⁶	Cynomolgus	Heart	TBI, TI, ATG, splenectomy, BMT
Smith¹⁴⁶	Cynomolgus	Kidney + BMT	TBI, BMT, anti-CD154, splenectomy, anti-CD8
Torrealba⁴⁶	Rhesus	Kidney	CD3-IT
Azimzedeh¹⁴⁷	Cynomolgus	Heart	Anti-CD154 + BMT +/− ATG
Schroder¹⁴⁸	Cynomolgus	Heart	Anti-CCR5 + CsA
Page¹⁴⁹	Rhesus	Kidney	CD3-IT, anti-LFA3, Tac
Kim¹⁵⁰	Rhesus	Kidney	(CD3-IT, anti-LFA3, Tac) plus belatacept or anti-CD40
Burghuber¹⁵¹	Rhesus	Kidney	bortezomib, anti-CD40, belatacept